Maternal Diet & gut Health: Compound Found to Reduce Risk of Childhood Fatty liver Disease
Table of Contents
A growing body of research suggests a link between a mother’s diet during pregnancy and breastfeeding and the future health of her child, particularly concerning the rising rates of fatty liver disease. New findings from the University of Oklahoma offer a potential pathway to mitigate this risk, identifying a naturally occurring compound that significantly lowered the incidence of the condition in animal models.
The study, published in the journal eBioMedicine, reveals that offspring of mice fed a high-fat, high-sugar diet during pregnancy and lactation experienced a dramatically reduced risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD) – formerly known as non-alcoholic fatty liver disease – when their mothers received a compound called indole. This discovery underscores the critical role of the gut microbiome in early growth and long-term health.
The Silent Epidemic of Childhood MASLD
MASLD is increasingly prevalent in both adults and children, but it frequently enough progresses more rapidly in younger patients and is closely associated with diabetes. According to one researcher involved in the study, the prevalence of MASLD in children reaches approximately 30% among those with obesity, and around 10% in children without obesity. “Unluckily, the risk is higher if a mother is obese or consumes a poor diet,” the researcher explained. “The disease in children is silent and typically isn’t discovered until a parent seeks help for their child for liver-related symptoms.”
Investigating the Microbiome’s Influence
Researchers,led by Jed Friedman,Ph.D., director of the OU Health Harold Hamm Diabetes Center, and Karen Jonscher, Ph.D., associate professor of biochemistry and physiology at the OU College of Medicine, sought to understand how gut bacteria influence the development of fatty liver disease. The team hypothesized that the maternal microbiome – the collection of microorganisms living in the mother’s gut – plays a crucial role in shaping the health of the offspring.
To test this,female mice were fed a Western-style diet,high in fat and sugar,throughout pregnancy and while nursing. A subset of these mice also received indole, a compound produced by beneficial gut bacteria when they break down tryptophan, an amino acid found in foods like turkey and nuts. After weaning, the offspring were initially placed on a standard diet before being switched to a Western-style diet to encourage the development of MASLD.
Indole’s Protective Effects: A Multi-Faceted Benefit
The results were striking. Offspring born to mothers who received indole exhibited meaningful health advantages. They demonstrated healthier livers, gained less weight, maintained lower blood sugar levels, and developed smaller fat cells, even after exposure to an unhealthy diet. Researchers also observed activation of a protective gut pathway involving the acyl hydrocarbon receptor (AHR).
Further analysis revealed a beneficial shift in liver fat composition. The study found no increase in harmful long-chain ceramides, while levels of beneficial very long-chain ceramides rose. Perhaps most compellingly, transferring gut bacteria from the protected offspring to mice that had not received indole resulted in reduced liver damage in the recipient animals, solidifying the microbiome’s central protective role.
Implications for Prevention and Future Research
While this research was conducted on animal models and cannot be directly translated to humans, the findings offer a promising avenue for preventing childhood MASLD through early intervention. currently, weight loss remains the only effective treatment for pediatric MASLD once the disease is established, and there are no approved medications.
“Anything we can do to improve the mother’s microbiome may help prevent the development of MASLD in the offspring,” Jonscher stated. “That would be far better than trying to reverse the disease once it has already progressed.” This research highlights the potential for dietary interventions or probiotic therapies aimed at bolstering the maternal microbiome as a proactive strategy to safeguard the liver health of future generations.
